Track the Suraksha Diagnostic Limited share price and the full management transaction log of the company, a listed equity based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Suraksha Diagnostic Limited has logged 17 reports. Market capitalisation: €15.9bn. The latest transaction was disclosed on 25 February 2026 (Purchase). Among the most active insiders: Dr. Somnath Chatterjee. Every trade is openly available.
17
Insider Decl.
n/a
Thresholds
€483,746
17 ops.
Buy Volume
n/a
n/a
Sell Volume
10Σ signal
Buys €483,746n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,250 of 29,057 companies
57.2
score / 100
Value
39
Quality
75
FCF yld0.9%
Earn yld2.0%
EV/EBITDA17.4x
ROE14%
Gross mgn88%
Net mgn10%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
7,590 shares@ ₹327.410914.6% of flowEquity SharesSEBI:57041b52df1adaabb578559bec9f2620aacda8e8
17 of 17 declarations
About Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is a company specializing in medical diagnostic services. It operates in the XBOM market and focuses on providing high-quality tests and analyses.